1304 related articles for article (PubMed ID: 17469323)
21. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy.
Ho PC; Ngai SW; Liu KL; Wong GC; Lee SW
Obstet Gynecol; 1997 Nov; 90(5):735-8. PubMed ID: 9351755
[TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion.
Liao AH; Han XJ; Wu SY; Xiao DZh; Xiong CL; Wu XR
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):211-6. PubMed ID: 15358467
[TBL] [Abstract][Full Text] [Related]
23. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan.
Kapp N; Todd CS; Yadgarova KT; Alibayeva G; Nazarova D; Loza O; Babadjanova GS
Contraception; 2007 Dec; 76(6):461-6. PubMed ID: 18061705
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic termination of second trimester pregnancies with intrauterine fetal death with 400 micrograms of oral misoprostol.
Pongsatha S; Tongsong T
J Obstet Gynaecol Res; 2004 Jun; 30(3):217-20. PubMed ID: 15210046
[TBL] [Abstract][Full Text] [Related]
25. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
[TBL] [Abstract][Full Text] [Related]
26. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of terminating biochemical pregnancy and early clinical pregnancy with mifepristone and misoprostol].
Li CL; Wei M; Fu MF; Li M
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):542-5. PubMed ID: 17983494
[TBL] [Abstract][Full Text] [Related]
28. Early pregnancy termination with mifepristone and misoprostol in Norway.
Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
[TBL] [Abstract][Full Text] [Related]
29. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
31. Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae.
Celentano C; Prefumo F; Di Andrea O; Presti F; Di Nisio Q; Rotmensch S
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):764-8. PubMed ID: 15255850
[TBL] [Abstract][Full Text] [Related]
32. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
Herabutya Y; Chanrachakul B; Punyavachira P
BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
[TBL] [Abstract][Full Text] [Related]
33. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
34. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial.
Dickinson JE; Godfrey M; Evans SF
J Matern Fetal Med; 1998; 7(3):115-9. PubMed ID: 9642607
[TBL] [Abstract][Full Text] [Related]
36. Second trimester pregnancy termination with 400 μg vaginal misoprostol: efficacy and safety.
Kunwar S; Saha PK; Goel P; Huria A; Tandon R; Sehgal A
Biosci Trends; 2010 Dec; 4(6):351-4. PubMed ID: 21248435
[TBL] [Abstract][Full Text] [Related]
37. Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
Stibbe KJ; de Weerd S
Arch Gynecol Obstet; 2012 Sep; 286(3):795-6. PubMed ID: 22434057
[No Abstract] [Full Text] [Related]
38. Low-dose vaginal misoprostol in the management of intrauterine fetal death.
El-Gharib MN; Elebyary MT
J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1239-42. PubMed ID: 21714693
[TBL] [Abstract][Full Text] [Related]
39. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
Tang OS; Chan CC; Kan AS; Ho PC
Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
[TBL] [Abstract][Full Text] [Related]
40. Termination of second-trimester pregnancy with intracervicovaginal misoprostol.
Srisomboon J; Tongsong T; Pongpisuttinun S
J Med Assoc Thai; 1997 Apr; 80(4):242-6. PubMed ID: 9175393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
